Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Spectral Capital (FCCN) Research & Development (2024)

Spectral Capital has reported Research & Development over the past 3 years, most recently at $196626.0 for Q4 2024.

  • For Q4 2024, Research & Development changed N/A year-over-year to $196626.0; the TTM value through Dec 2025 reached $196626.0, down 73.61%, while the annual FY2024 figure was $745024.0, N/A changed from the prior year.
  • Research & Development for Q4 2024 was $196626.0 at Spectral Capital, down from $548398.0 in the prior quarter.
  • Over five years, Research & Development peaked at $548398.0 in Q3 2024 and troughed at $196626.0 in Q4 2024.